missing translation for 'onlineSavingsMsg'
Learn More

SREBP1 Mouse anti-Human, Clone: SREBP1/1578, Novus Biologicals™

Mouse Monoclonal Antibody

€ 484.00

Specifications

Antigen SREBP1
Clone SREBP1/1578
Concentration 0.2 mg/mL
Dilution ELISA
Applications Immunohistochemistry (Paraffin)
View More Specs

Products 1
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
18639487
View Documents
Novus Biologicals
NBP3-07878-100ug
100 μg
€ 484.00
100µg
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
Description

Description

SREBP1 Monoclonal specifically detects SREBP1 in Human samples. It is validated for ELISA.
Specifications

Specifications

SREBP1
0.2 mg/mL
Immunohistochemistry (Paraffin)
Unconjugated
Mouse
Cancer, Cholesterol Metabolism, Chromatin Research, Diabetes Research, Lipid and Metabolism, Transcription Factors and Regulators
10 mM PBS with 0.05% BSA
6720
IgG1 κ
Protein A or G purified
SREBP1/1578
ELISA
Monoclonal
Purified
RUO
Human
BHLHD1, Class D basic helix-loop-helix protein 1, SREBP 1c, SREBP-1, SREBP1bHLHd1SREBP-1c, sterol regulatory element binding protein-1, sterol regulatory element binding transcription factor 1, sterol regulatory element-binding protein 1, Sterol regulatory element-binding transcription factor 1
Recombinant full-length human SREBP1 protein
Primary
Store at 4°C.
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.